158 related articles for article (PubMed ID: 25771089)
1. [The genetics of thrombosis in cancer].
Soria JM; López S
Med Clin (Barc); 2015 Jan; 144 Suppl 1():26-30. PubMed ID: 25771089
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
3. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.
Muñoz A; Ay C; Grilz E; López S; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Ortega L; Rupérez A; Salas E; Pabinger I; Soria JM
J Clin Oncol; 2023 Jun; 41(16):2911-2925. PubMed ID: 36730884
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
5. [Management of thromboembolic risk in patients with cancer].
Trujillo Santos AJ
Med Clin (Barc); 2012 Oct; 139 Suppl 2():31-5. PubMed ID: 23498070
[TBL] [Abstract][Full Text] [Related]
6. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.
Muñoz Martín AJ; Ortega I; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Rupérez A; Souto JC; Martín M; Salas E; Soria JM
Br J Cancer; 2018 Apr; 118(8):1056-1061. PubMed ID: 29588512
[TBL] [Abstract][Full Text] [Related]
7. Prediction of postdischarge venous thromboembolism using a risk assessment model.
Iannuzzi JC; Young KC; Kim MJ; Gillespie DL; Monson JR; Fleming FJ
J Vasc Surg; 2013 Oct; 58(4):1014-20.e1. PubMed ID: 23683384
[TBL] [Abstract][Full Text] [Related]
8. [Predictive Khorana's model in patients with venous thromboembolic disease and cancer].
Ugarte Fornell G; Otero Candelera R; Ferrer Galván M; Morillo Guerrero R; Elias Hernández T; Jara Palomares L
Med Clin (Barc); 2013 Dec; 141(11):479-81. PubMed ID: 23790582
[TBL] [Abstract][Full Text] [Related]
9. Multilocus genetic risk scores for venous thromboembolism risk assessment.
Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
[TBL] [Abstract][Full Text] [Related]
10. Cancer and venous thrombosis: current comprehensions and future perspectives.
Lauw MN; van Doormaal FF; Middeldorp S; Buller HR
Semin Thromb Hemost; 2013 Jul; 39(5):507-14. PubMed ID: 23629821
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in cancer patients: risk assessment, prevention and management.
Tukaye DN; Brink H; Baliga R
Future Cardiol; 2016 Mar; 12(2):221-35. PubMed ID: 26919091
[TBL] [Abstract][Full Text] [Related]
12. Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism.
Rubio-Terrés C; Soria JM; Morange PE; Souto JC; Suchon P; Mateo J; Saut N; Rubio-Rodríguez D; Sala J; Gracia A; Pich S; Salas E
Appl Health Econ Health Policy; 2015 Apr; 13(2):233-42. PubMed ID: 25652150
[TBL] [Abstract][Full Text] [Related]
13. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
Pelletier R
J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
[TBL] [Abstract][Full Text] [Related]
14. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.
Connolly GC; Khorana AA
Thromb Res; 2010 Apr; 125 Suppl 2():S1-7. PubMed ID: 20433985
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
16. [Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"].
Dávid M; Losonczy H; Udvardy M; Boda Z; Blaskó G; Tar A; Pfliegler G
Orv Hetil; 2010 Aug; 151(34):1365-74. PubMed ID: 20705551
[TBL] [Abstract][Full Text] [Related]
17. Genetics in thrombophilia. An update.
Reitsma PH
Hamostaseologie; 2015; 35(1):47-51. PubMed ID: 25465384
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations for thromboembolic disease in oncological processes. A view from primary care].
García Vallejo O; Aicart Bort MD; Babiano Fernández MÁ; Caballer Rodilla J; Cabrera Ferriols MÁ; Carrasco Carrasco E; Gil Gil I; Lahera García AM; Martos Cárdenas T; Piera Carbonell A
Semergen; 2023 Oct; 49(7):102030. PubMed ID: 37487423
[TBL] [Abstract][Full Text] [Related]
19. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
20. Tests predictive of thrombosis in cancer.
Ay C; Pabinger I
Thromb Res; 2010 Apr; 125 Suppl 2():S12-5. PubMed ID: 20433990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
